PTGS2 and lung carcinoma: COX-2 enhances immunosurveillance escape which is demonstrated by the finding that inhibiting COX-2/PGE2 in animals with lung cancer reduces Treg-cell frequencies while increasing the frequency of anti-tumor effector T cells [64].